Studies to identify the mechanism of the increase in tyrosine-phosphorylated STAT3 levels (Fig. 1D) were undertaken due to the importance of this transcription factor in CLL biology (Tomic et al., 2011; Li et al., 2015; Spaner et al., 2016). This evidence concerns the gene STAT3 and B-cell chronic lymphocytic leukemia.